NovaBay Pharmaceuticals To Present At JMP Securities 8th Annual Healthcare Conference

EMERYVILLE, Calif., July 2, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biotechnology company focused on the topical, anti-infective market, today announced that Ron Najafi, Ph.D., Chairman and CEO of NovaBay Pharmaceuticals, will present a corporate and clinical update at the 8th Annual JMP Securities Healthcare Conference, held July 9-10, 2013 in New York City. Ron Najafi and Tom Paulson, Chief Financial Officer of NovaBay, will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.
Event: JMP Securities Healthcare Conference
Date: Wednesday, July 10, 2013
Time: 4:00 pm EDT
Place: New York City

To access the live audio webcast of this presentation, please log on through a link located in the News & Events section of NovaBay's website at http://novabay.com/investors/events . A replay of the webcast will be available one hour after the conclusion of the live event.

About NovaBay Pharmaceuticals, Inc.

Going Beyond Antibiotics

NovaBay Pharmaceuticals is a biotechnology company focused on addressing the large unmet therapeutic needs of the global, topical anti-infective market with auriclosene. The Company's four core business units – DermaBay, UroBay, EyeBay and MediBay – are developing products in dermatology, urology, ophthalmology, and wound care areas.
Stay informed on NovaBay's progress:
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Join us on Google+
Visit NovaBay's Website
CONTACT: NovaBay Pharmaceuticals Contacts         Thomas J. Paulson         Chief Financial Officer         510-899-8809         tjpaulson@novabaypharma.com                  Ana Kapor         Director, Investor Relations and Corporate Communications         NovaBay Pharmaceuticals, Inc.         510-899-8889         akapor@novabaypharma.com

If you liked this article you might like

3 Biotech Stocks Under $10 to Trade for Big Breakouts

Novabay Pharmaceuticals (NBY) Stock Spikes After FDA Approves Disinfection System

Insider Trading Alert - NBY, WPX And KTOS Traded By Insiders

Insider Trading Alert - EVTC, CRM And NBY Traded By Insiders

Insider Trading Alert - CGIX, NBY And BIOA Traded By Insiders